Gene-based therapy of malignant melanoma
Melanoma continues to present a major therapeutic challenge to oncologists, oncologic surgeons, and dermatologists. Recent advances in molecular genetics and improvement in our understanding of immune responses to tumors have generated an interest in using gene-based treatment strategies to fight me...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1 October 2005
|
| In: |
Seminars in oncology
Year: 2002, Jahrgang: 29, Heft: 5, Pages: 503-512 |
| ISSN: | 1532-8708 |
| DOI: | 10.1053/sonc.2002.35245 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1053/sonc.2002.35245 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0093775402502967 
|
| Verfasserangaben: | Dirk Schadendorf |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1738932508 | ||
| 003 | DE-627 | ||
| 005 | 20220819025215.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201117r20052002xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1053/sonc.2002.35245 |2 doi | |
| 035 | |a (DE-627)1738932508 | ||
| 035 | |a (DE-599)KXP1738932508 | ||
| 035 | |a (OCoLC)1341377721 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 245 | 1 | 0 | |a Gene-based therapy of malignant melanoma |c Dirk Schadendorf |
| 264 | 1 | |c 1 October 2005 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Elektronische Reproduktion der Druckausgabe | ||
| 500 | |a Gesehen am 17.11.2020 | ||
| 520 | |a Melanoma continues to present a major therapeutic challenge to oncologists, oncologic surgeons, and dermatologists. Recent advances in molecular genetics and improvement in our understanding of immune responses to tumors have generated an interest in using gene-based treatment strategies to fight melanoma. Several basic strategies have emerged: (1) strengthening of the immune response against tumors by genetic modification of some target cell populations of the host using immunostimulatory genes such as cytokines and by genetic immunization with the genes coding for melanoma-associated antigens recognized by cytotoxic T cells; (2) interference with signaling cascades; and (3) suicide gene strategies. This article reviews these novel strategies and summarizes the most recent data generated by European groups either in experimental studies or in clinical trials. Semin Oncol 29:503-512. Copyright 2002, Elsevier Science (USA). All rights reserved. | ||
| 534 | |c 2002 | ||
| 773 | 0 | 8 | |i Enthalten in |t Seminars in oncology |d Amsterdam [u.a.] : Elsevier, 2001 |g 29(2002), 5, Seite 503-512 |h Online-Ressource |w (DE-627)34306247X |w (DE-600)2073537-6 |w (DE-576)099718340 |x 1532-8708 |7 nnas |a Gene-based therapy of malignant melanoma |
| 773 | 1 | 8 | |g volume:29 |g year:2002 |g number:5 |g pages:503-512 |g extent:10 |a Gene-based therapy of malignant melanoma |
| 856 | 4 | 0 | |u https://doi.org/10.1053/sonc.2002.35245 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0093775402502967 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201117 | ||
| 993 | |a Article | ||
| 994 | |a 2002 | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1738932508 |e 3805818106 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Schadendorf","given":"Dirk","roleDisplay":"VerfasserIn","display":"Schadendorf, Dirk","role":"aut"}],"title":[{"title_sort":"Gene-based therapy of malignant melanoma","title":"Gene-based therapy of malignant melanoma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Elektronische Reproduktion der Druckausgabe","Gesehen am 17.11.2020"],"language":["eng"],"recId":"1738932508","name":{"displayForm":["Dirk Schadendorf"]},"origin":[{"dateIssuedDisp":"1 October 2005","dateIssuedKey":"2005"}],"id":{"eki":["1738932508"],"doi":["10.1053/sonc.2002.35245"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"id":{"issn":["1532-8708"],"zdb":["2073537-6"],"eki":["34306247X"]},"origin":[{"dateIssuedDisp":"2001-","publisher":"Elsevier ; Saunders","dateIssuedKey":"2001","publisherPlace":"Amsterdam [u.a.] ; Philadelphia, Pa."}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Seminars in oncology","title_sort":"Seminars in oncology"}],"language":["eng"],"recId":"34306247X","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 24.06.25"],"disp":"Gene-based therapy of malignant melanomaSeminars in oncology","part":{"pages":"503-512","issue":"5","year":"2002","extent":"10","text":"29(2002), 5, Seite 503-512","volume":"29"},"pubHistory":["Nachgewiesen 28.2001 -"]}]} | ||
| SRT | |a SCHADENDORGENEBASEDT1200 | ||